help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vijayaraghavan, S.
Right arrow Articles by Kopelman, P. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vijayaraghavan, S.
Right arrow Articles by Kopelman, P. G.

Journal of Clinical Endocrinology & Metabolism, Vol 79, 568-570, Copyright © 1994 by Endocrine Society


ARTICLES

Apolipoprotein-D polymorphism: a genetic marker for obesity and hyperinsulinemia

S Vijayaraghavan, GA Hitman and PG Kopelman
Medical Unit, Royal London Hospital, United Kingdom.

Obesity frequently clusters with hypertension, hyperlipidemia, non- insulin-dependent diabetes mellitus, and ischemic heart disease with hyperinsulinemia as syndrome X. Although central obesity has been recognized to have a strong genetic component, few candidate genes have been studied in this disorder. After a recently described association between the apolipoprotein-D (Apo-D) gene polymorphism and non-insulin- dependent diabetes mellitus by our group, we have now looked at a TaqI polymorphism of the Apo-D gene in two other components of syndrome X, namely obesity and hyperinsulinemia. Apo-D genotype differences were found between obese subjects (n = 57) and slim controls (n = 57; P = 0.006). Furthermore, in the obese group an association was found between the Apo-D genotype and fasting insulin (P < 0.001). Preliminary evidence, therefore, suggests that the TaqI Apo-D polymorphism can be used as a genetic marker for obesity and several components of syndrome X.


This article has been cited by other articles:


Home page
Physiol. GenomicsHome page
Y.-W. Chen, C. M. Gregory, M. T. Scarborough, R. Shi, G. A. Walter, and K. Vandenborne
Transcriptional pathways associated with skeletal muscle disuse atrophy in humans
Physiol Genomics, November 14, 2007; 31(3): 510 - 520.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
J. E. Larkin, B. C. Frank, R. M. Gaspard, I. Duka, H. Gavras, and J. Quackenbush
Cardiac transcriptional response to acute and chronic angiotensin II treatments
Physiol Genomics, July 8, 2004; 18(2): 152 - 166.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Hummasti, B. A. Laffitte, M. A. Watson, C. Galardi, L. C. Chao, L. Ramamurthy, J. T. Moore, and P. Tontonoz
Liver X receptors are regulators of adipocyte gene expression but not differentiation: identification of apoD as a direct target
J. Lipid Res., April 1, 2004; 45(4): 616 - 625.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
Y. Mori, S. Otabe, C. Dina, K. Yasuda, C. Populaire, C. Lecoeur, V. Vatin, E. Durand, K. Hara, T. Okada, et al.
Genome-Wide Search for Type 2 Diabetes in Japanese Affected Sib-Pairs Confirms Susceptibility Genes on 3q, 15q, and 20q and Identifies Two New Candidate Loci on 7p and 11p
Diabetes, April 1, 2002; 51(4): 1247 - 1255.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
N. Viguerie, L. Millet, S. Avizou, H. Vidal, D. Larrouy, and D. Langin
Regulation of Human Adipocyte Gene Expression by Thyroid Hormone
J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 630 - 634.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. L. Rainwater, L. Almasy, J. Blangero, S. A. Cole, J. L. VandeBerg, J. W. MacCluer, and J. E. Hixson
A Genome Search Identifies Major Quantitative Trait Loci on Human Chromosomes 3 and 4 That Influence Cholesterol Concentrations in Small LDL Particles
Arterioscler. Thromb. Vasc. Biol., March 1, 1999; 19(3): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. C. Mahaney, J. Blangero, A. G. Comuzzie, J. L. VandeBerg, M. P. Stern, and J. W. MacCluer
Plasma HDL Cholesterol, Triglycerides, and Adiposity : A Quantitative Genetic Test of the Conjoint Trait Hypothesis in the San Antonio Family Heart Study
Circulation, December 1, 1995; 92(11): 3240 - 3248.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1994 by The Endocrine Society